Lynley Marshall is a consultant in paediatric and adolescent oncology drug development at the Royal Marsden Hospital in London, where she leads the Paediatric and Adolescent Oncology Drug Development team.[1]
After completing her undergraduate training in Johannesburg, South Africa, and south west England, Marshall trained in paediatrics and then as a paediatric oncologist in University of Bristol and Oxford University. She holds a Ph.D. from the Institute of Cancer Research. [2]
Marshall chairs the National Cancer Research Institute Children's cancer and Leukaemia Clinical Studies Novel Agents Subgroup,[3] and is a member of the Innovative Therapies for Children with Cancer (ITCC) European Early Phase Trials Consortium.[4]
References
edit- ^ "Interview with Dr Lynley Marshall, Royal Marsden paediatric ECMC | ECMC". www.ecmcnetwork.org.uk. Retrieved 4 November 2022.
- ^ "Dr Lynley Marshall". Royal Marsden. Retrieved 16 September 2020.
- ^ "NCRI Groups". NCRI Groups. Retrieved 16 September 2020.
- ^ "ITCC Clinical Trial Committee". ITCC Clinical Trials Committee. Retrieved 16 September 2020.
   | This English biographical article related to medicine is a stub. You can help Wikipedia by expanding it. |